Product Program year 2020 Source: CMS Open Payments

Cusa Clarity

Device Neuro Critical Care

Open in the dashboard

General payments

$433,341

1,667 payments

Research payments

$0

0 payments

Through program year 2020, $433,341 in general payments and $0 in research payments were reported against Cusa Clarity (Neuro Critical Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $173,208 522
2019 General $260,133 1,145

Breakdown

Who paid General payments · program years 2019–2020
  1. Integra LifeSciences Corporation $432,630 1,641 payments
  2. Arkis Biosciences Inc $712 26 payments
Top recipients General payments · program year 2020
  1. Boca Raton Regional Hospital Teaching hospital · FL $42,964 25% · 8 payments
  2. Jogi Pattisapu Neurological Surgery · Orlando, FL $36,838 21% · 10 payments
  3. Gerald Grant Neurological Surgery · Stanford, CA $15,092 9% · 2 payments
  4. Brian Jankowitz Neurological Surgery · Philadelphia, PA $7,827 5% · 1 payment
  5. Michael Muhonen Neurological Surgery · Orange, CA $7,349 4% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Neurological Surgery $96,291 80% · 247 practitioners
  2. Orthopaedic Surgery $7,827 7% · 5 practitioners
  3. Blood Banking & Transfusion Medicine Pathology $6,500 5% · 1 practitioner
  4. Surgery $3,544 3% · 20 practitioners
  5. Surgical Oncology Surgery $2,287 2% · 6 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $88,700 51% · 42 recipients
  2. California $33,898 20% · 61 recipients
  3. New Jersey $8,281 5% · 7 recipients
  4. Pennsylvania $7,179 4% · 12 recipients
  5. Colorado $6,781 4% · 6 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,667 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record